Mesothelioma and thymic tumors: Treatment challenges in (outside) a network setting
2018; Elsevier BV; Volume: 45; Issue: 1 Linguagem: Inglês
10.1016/j.ejso.2018.01.078
ISSN1532-2157
AutoresMartina Imbimbo, Jean‐Michel Maury, Marina Chiara Garassino, Nicolas Girard, Monika Hackl, E. Van Eycken, K. Henau, Nadya Dimitrova, Mario Šekerija, Ladislav Dušek, Margit Mägi, Nea Malila, Maarit K. Leinonen, Michel Velten, Xavier Troussard, Véronique Bouvier, Anne‐Valérie Guizard, Anne–Marie Bouvier, P. Arveux, Marc Maynadié, Anne‐Sophie Woronoff, Michel Robaszkiewicz, Isabelle Baldi, Alain Monnereau, Brigitte Trétarre, Marc Colonna, F. Molinié, Simona Bara, C. Schvartz, B. Lapôtre‐Ledoux, Pascale Grosclaude, Roland Stabenow, Sabine Luttmann, Alice Nennecke, Jutta Engel, G. Schubert-Fritschle, Jan Heidrich, Bernd Holleczek, Jón G. Jónasson, Kerri M. Clough‐Gorr, Harry Comber, Guido Mazzoleni, Adriano Giacomin, Antonella Sutera Sardo, Alessandro Barchielli, Diego Serraino, Roberta De Angelis, Sandra Mallone, Andrea Tavilla, Daniela Pierannunzio, Silvia Rossi, Mariano Santaquilani, Arnold Knijn, Fabio Pannozzo, Valerio Gennaro, Lucia Benfatto, Paolo Ricci, M. Autelitano, Gianbattista Spagnoli, Mario Fusco, M. Usala, Francesco Vitale, Maria Michiara, Rosario Tumino, Lucìa Mangone, Fabio Falcini, Stefano Ferretti, Rosangela Filiberti, Enza Marani, Arturo Iannelli, Flavio Sensi, Silvano Piffer, Maria Gentilini, A Madeddu, Antonio Ziino, S. Maspero, P. Candela, Fabrizio Stracci, Giovanna Tagliabue, Massimo Rugge, Annalisa Trama, Gemma Gatta, Laura Botta, Riccardo Capocaccia, Santa Pildava, Giedrė Smailytė, Neville Calleja, Tom Børge Johannesen, Jadwiga Rachtan, Stanisław Góźdż, Jerzy Błaszczyk, Kamila Kępska, G. Forjaz de Lacerda, María José Bento, Ana Miranda, C. Safaei Diba, E. Almar, Nerea Larrañaga, Arantza López de Munain, A. Torrella-Ramos, J.M. Díaz García, Rafael Marcos‐Gragera, María‐José Sánchez, Carmen Navarro, Diego Salmerón, Conchi Moreno‐Iribas, Jaume Galcerán, Marià Carulla, Seyed Mohsen Mousavi, Christine Bouchardy, Silvia M. Ess, Andrea Bordoni, Isabelle Konzelmann, Jem Rashbass, Anna Gavin, David Brewster, Dyfed Huws, Otto Visser, Magdalena Bielska‐Lasota, Maja Primic‐Žakelj, Ian Kunkler, E Benhamou,
Tópico(s)Pleural and Pulmonary Diseases
ResumoThe management of patients with mesothelioma and thymic malignancy requires continuous multidisciplinary expertise at any step of the disease. A dramatic improvement in our knowledge has occurred in the last few years, through the development of databases, translational research programs, and clinical trials. Access to innovative strategies represents a major challenge, as there is a lack of funding for clinical research in rare cancers and their rarity precludes the design of robust clinical trials that could lead to specific approval of drugs. In this context, patient-centered initiatives, such as the establishment of dedicated networks, are warranted. International societies, such as IMIG (International Mesothelioma Interest Group) and ITMIG (International Thymic Malignancy Interest Group) provide infrastructure for global collaboration, and there are many advantages to having strong regional groups working on the same issues. There may be regional differences in risk factors, susceptibility, management and outcomes. The ability to address questions both regionally as well as globally is ideal to develop a full understanding of mesothelioma and thymic malignancies. In Europe, through the integration of national networks with EURACAN, the collaboration with academic societies and international groups, the development of networks in thoracic oncology provides multiplex integration of clinical care and research, ultimately ensuring equal access to high quality care to all patients, with the opportunity of conducting high level clinical and translational research projects.
Referência(s)